# Liu Feihong

> Liu Feihong is a Series B investor at Huajin Capital backing Health Care. See 3 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Huajin Capital](https://shizune.co/investors/profile/huajin-capital)
- Total investments: 3
- Last investment: Jul 2023
- Lead investor: 33%
- Last updated: Aug 2026

Liu Feihong is a Series B investor at Huajin Capital focused on Health Care and Biopharma. Liu Feihong is the Managing Director of Huajin Capital.

## Contacts

5 contacts available for Liu Feihong: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/liu-feihong?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Biopharma | 1 | 33% |
| CleanTech | 1 | 33% |
| Clean Energy | 1 | 33% |
| Biotechnology | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 33% |
| Series D | 1 | 33% |
| Debt Financing | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| OptoMedic | OptoMedic is specializing in the research and development and production of high-end optical medical devices and systems. |  | Debt Financing | Jul 12, 2023 |  |
| Singularity Energy Technology | Singularity Energy is committed to core technology research and product development in advanced energy storage systems, and contributes industry-leading solutions to promote large-scale clean energy integration and achieve global carbon neutrality goals. | $99.5M | Series B | May 18, 2023 |  |
| Hygea Medical Technology | Hygea Medical Technology is a oncology-focused biopharma company. Hygea’s solutions cater to cancer therapies targeting diseases in the lung, liver, breast, and kidney. Hygea will continue to develop its micro-invasive and Cryo-HITTM technology. | $14.6M | Series D | Feb 15, 2023 |  |

3 of 3 investments shown.

## Co-investors
- [Qiandao Fund](https://shizune.co/investors/profile/qiandao-fund) — VC Fund, 2 deals together
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 1 deal together
- [Binfu Capital](https://shizune.co/investors/profile/binfu-capital) — VC Fund, 1 deal together
- [CCB Equity](https://shizune.co/investors/profile/ccb-equity) — VC Fund, 1 deal together
- [GoldStone Investment](https://shizune.co/investors/profile/citic-goldstone-investment-fund) — VC Fund, 1 deal together
- [Guoxin Investment](https://shizune.co/investors/profile/guoxin-investment) — VC Fund, 1 deal together

## About Huajin Capital

VC Fund · Zhuhai, China

Huajin Capital engages in equity investment, asset management, physical, and incubator.

1 contacts available at Huajin Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Liu Feihong | Managing Director | — |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Liu Feihong invest in?

Liu Feihong invests primarily in Health Care, Biopharma and CleanTech startups, most often at Series B and Series D stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Liu Feihong?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Liu Feihong last invest?

The most recent investment recorded for Liu Feihong closed in Jul 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co